These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26663190)

  • 1. Essential Role of microRNA in Skin Physiology and Disease.
    Glavač D; Ravnik-Glavač M
    Adv Exp Med Biol; 2015; 888():307-30. PubMed ID: 26663190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of microRNAs in autoimmune diseases with skin involvement.
    Deng X; Su Y; Wu H; Wu R; Zhang P; Dai Y; Chan TM; Zhao M; Lu Q
    Scand J Immunol; 2015 Mar; 81(3):153-65. PubMed ID: 25430682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as biological regulators in skin disorders.
    Singhvi G; Manchanda P; Krishna Rapalli V; Kumar Dubey S; Gupta G; Dua K
    Biomed Pharmacother; 2018 Dec; 108():996-1004. PubMed ID: 30372911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of microRNAs in skin morphogenesis and diseases.
    Bostjancic E; Glavac D
    Acta Dermatovenerol Alp Pannonica Adriat; 2008 Sep; 17(3):95-102. PubMed ID: 18853072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of microRNAs in the pathogenesis of systemic lupus erythematosus.
    Miao CG; Yang YY; He X; Huang C; Huang Y; Zhang L; Lv XW; Jin Y; Li J
    Cell Signal; 2013 Sep; 25(9):1828-36. PubMed ID: 23707525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circulating cell-free microRNA profile in systemic sclerosis is distinct from both healthy controls and systemic lupus erythematosus.
    Steen SO; Iversen LV; Carlsen AL; Burton M; Nielsen CT; Jacobsen S; Heegaard NH
    J Rheumatol; 2015 Feb; 42(2):214-21. PubMed ID: 25399392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets.
    Long H; Wang X; Chen Y; Wang L; Zhao M; Lu Q
    Cancer Lett; 2018 Aug; 428():90-103. PubMed ID: 29680223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as novel players in skin development, homeostasis and disease.
    Schneider MR
    Br J Dermatol; 2012 Jan; 166(1):22-8. PubMed ID: 21824129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNAs in the Pathogenesis of Systemic Lupus Erythematosus.
    Qu B; Shen N
    Int J Mol Sci; 2015 Apr; 16(5):9557-72. PubMed ID: 25927578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA involvement in lupus: the beginning of a new tale.
    Liang D; Shen N
    Curr Opin Rheumatol; 2012 Sep; 24(5):489-98. PubMed ID: 22732688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.
    Dai Y; Huang YS; Tang M; Lv TY; Hu CX; Tan YH; Xu ZM; Yin YB
    Lupus; 2007; 16(12):939-46. PubMed ID: 18042587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiles of peripheral blood mononuclear cells in patients with systemic lupus erythematosus.
    Liu D; Zhao H; Zhao S; Wang X
    Acta Histochem; 2014 Jun; 116(5):891-7. PubMed ID: 24657071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression.
    Stagakis E; Bertsias G; Verginis P; Nakou M; Hatziapostolou M; Kritikos H; Iliopoulos D; Boumpas DT
    Ann Rheum Dis; 2011 Aug; 70(8):1496-506. PubMed ID: 21602271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature.
    Huang RY; Li L; Wang MJ; Chen XM; Huang QC; Lu CJ
    Medicine (Baltimore); 2015 Nov; 94(45):e2030. PubMed ID: 26559308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs in inflammatory skin diseases and their clinical implications.
    Løvendorf MB; Skov L
    Expert Rev Clin Immunol; 2015 Apr; 11(4):467-77. PubMed ID: 25719822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs: Emerging Regulators of Immune-Mediated Diseases.
    Tomankova T; Petrek M; Gallo J; Kriegova E
    Scand J Immunol; 2012 Feb; 75(2):129-41. PubMed ID: 21988491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
    Domingo S; Solé C; Moliné T; Ferrer B; Cortés-Hernández J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in the pathogenesis of systemic lupus erythematosus.
    Ma X; Liu Q
    Int J Rheum Dis; 2013 Apr; 16(2):115-21. PubMed ID: 23773633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis.
    Shen N; Liang D; Tang Y; de Vries N; Tak PP
    Nat Rev Rheumatol; 2012 Dec; 8(12):701-9. PubMed ID: 23070646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.